Video
Author(s):
Before closing out their discussion on novel therapies in multiply relapsed multiple myeloma, panelists identify the evolving role of CAR T-cell therapy.
Pending Dato-DXd Approval Solidifies Importance of Sequencing in HR+ Breast Cancer
Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting
Neoadjuvant Therapy Selection: Are Abbreviated Regimens an Option in HER2+ Breast Cancer?
Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa
Research With ctDNA Continues to Pave the Way Toward Optimal Breast Cancer Management
De-Escalation Strategies, Biomarkers Could Refine Treatment Algorithm for Early-Stage HER2+ Breast Cancer
Dr Backhus on Surgical Eligibility in Borderline Resectable NSCLC
Dr Herbst on the Importance of Multidisciplinary Collaboration in NSCLC
Enhanced Clinical Education and Simplified Guidelines Needed to Address Germline Testing Gaps in Breast Cancer
Research Propels Additional Options into the Advanced HER2+ Breast Cancer Armamentarium